IRF1 and neoplasm: STAT1 has been initially considered to act exclusively as tumor suppressor and key regulator of the surveillance of developing tumors, primarily by activating growth-inhibitory and pro-apoptotic signaling in tumor cells, mainly mediated by IRF1 [511–514].